Your session is about to expire
← Back to Search
Overdose Prevention Support for Overdoses (POP Trial)
N/A
Waitlist Available
Led By Kelly Doran, MD, MHS
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up month 36
Awards & highlights
POP Trial Summary
This trial will study how to implement evidence-based practices to prevent overdose in Permanent Supportive Housing settings. It'll use a toolkit, champions, facilitation, & learning collaboratives.
Who is the study for?
This trial is for adults over 18 who either live in or work at participating Permanent Supportive Housing (PSH) buildings in New York. It's focused on those who can read and respond to surveys or participate in interviews in English. Children under 18 are not eligible.Check my eligibility
What is being tested?
The study tests overdose prevention strategies within PSH settings, including an implementation toolkit, champions for the cause among tenants and staff, limited practice facilitation, and learning collaboratives.See study design
What are the potential side effects?
Since this trial involves implementing support systems rather than medical interventions, traditional side effects like you'd see with medications aren't applicable here.
POP Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ month 36
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~month 36
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Fidelity Checklist Score
Secondary outcome measures
Acceptability of Intervention Measure (AIM) Score
Adoption Checklist Score
Brief Opioid Overdose Knowledge (BOOK) Survey Score
+8 morePOP Trial Design
4Treatment groups
Experimental Treatment
Group I: Cluster 4Experimental Treatment1 Intervention
Buildings randomized to Cluster 3 will receive the CSH-delivered intervention at Months 23-28. Tenant surveys will be administered 1 month prior to and 12 months following the start of the intervention period.
At all clusters, an all-staff survey will be administered at Months 1, 8, 15, 22, and 29. A sustainment survey will be administered to selected staff-leaders in the 8th month following the end of the intervention period.
Group II: Cluster 3Experimental Treatment1 Intervention
Buildings randomized to Cluster 3 will receive the CSH-delivered intervention at Months 16-21. Tenant surveys will be administered 1 month prior to and 12 months following the start of the intervention period.
At all clusters, an all-staff survey will be administered at Months 1, 8, 15, 22, and 29. A sustainment survey will be administered to selected staff-leaders in the 8th month following the end of the intervention period.
Group III: Cluster 2Experimental Treatment1 Intervention
Buildings randomized to Cluster 2 will receive the CSH-delivered intervention at Months 9-14. Tenant surveys will be administered 1 month prior to and 12 months following the start of the intervention period.
At all clusters, an all-staff survey will be administered at Months 1, 8, 15, 22, and 29. A sustainment survey will be administered to selected staff-leaders in the 8th month following the end of the intervention period.
Group IV: Cluster 1Experimental Treatment1 Intervention
Buildings randomized to Cluster 1 will receive the CSH-delivered intervention at Months 2-7. Tenant surveys will be administered 1 month prior to and 12 months following the start of the intervention period.
At all clusters, an all-staff survey will be administered at Months 1, 8, 15, 22, and 29. A sustainment survey will be administered to selected staff-leaders in the 8th month following the end of the intervention period.
Find a Location
Who is running the clinical trial?
National Institute on Drug Abuse (NIDA)NIH
2,470 Previous Clinical Trials
2,618,381 Total Patients Enrolled
5 Trials studying Overdose
1,645 Patients Enrolled for Overdose
NYU Langone HealthLead Sponsor
1,369 Previous Clinical Trials
839,248 Total Patients Enrolled
1 Trials studying Overdose
500 Patients Enrolled for Overdose
Kelly Doran, MD, MHSPrincipal InvestigatorNYU Langone Health
1 Previous Clinical Trials
40 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I live in supportive housing, am over 18, and can complete a survey in English or Spanish.I am 18 years old or older.I work (or have worked within 6 months) at a PSH building, am over 18, and can complete an English survey.I work or live in a PSH building, am over 18, and speak English.
Research Study Groups:
This trial has the following groups:- Group 1: Cluster 1
- Group 2: Cluster 2
- Group 3: Cluster 3
- Group 4: Cluster 4
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are any more volunteers being accepted for this research project?
"According to clinicaltrials.gov, this research endeavour is not presently enrolling participants. While the first post date was September 1st 2023 and last update March 14th 2023, there are still twenty other trials actively searching for volunteers."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger